Old Web
English
Sign In
Acemap
>
Paper
>
Clinical efficacy and safety of adalimumab for psoriatic arthritis: 48-week results of ADEPT
Clinical efficacy and safety of adalimumab for psoriatic arthritis: 48-week results of ADEPT
2005
Philip J. Mease
Dafna D. Gladman
Christopher T. Ritchlin
Eric Ruderman
Ernest Choy
Serge Steinfeld
Renee J. Perdok
Eric H. Sasso
M. A. Weinberg
Keywords:
Adept
Medicine
Physical therapy
Psoriatic arthritis
Adalimumab
clinical efficacy
Diabetes mellitus
Immunology
Dermatology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]